Skip to main content
. 2019 Jan 31;9(4):819–831. doi: 10.1016/j.apsb.2019.01.018

Figure 5.

Fig. 5

Representative flow cytometry plots showing percentages of tumor-infiltrating CD3e+CD4+ killer T cells (A), CD3e+CD8+ effector T cells (B) and CD4+FoxP3+ regulatory T cells (C) in solid tumors after various treatments indicated. From left to right are groups of Hepes, free DOX & IMQ, LT-DOX, LT-DOX+LT-IMQ, LT-DOX+LT-IMQ+anti-PD-L1. Proportions of CD3e+CD4+ effector T cells (C), CD3e+CD8+ T cells (D) and CD4+FoxP3+ regulatory T cells (E). (G) CD4+CTLs/Treg ratios and CD8+ effector T cells/Treg cells ratios in the solid tumors upon various treatments. Cytokine levels of TNF-α (H), and IFN-γ (I) in sera from mice isolated on day 3 after various treatments. Three mice were measured in each group in A–I. Data are mean ± SD, n = 3; *P < 0.05; **P < 0.01; and ***P < 0.001.

HHS Vulnerability Disclosure